Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol-Reference-Cited by-同舟云学术

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol

Published:2017-05-01 Issue:5 Volume:2 Page:547
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Giugliano Robert P.¹,Wiviott Stephen D.¹,Blazing Michael A.²,De Ferrari Gaetano M.³,Park Jeong-Gun¹,Murphy Sabina A.¹,White Jennifer A.²,Tershakovec Andrew M.⁴,Cannon Christopher P.¹,Braunwald Eugene¹

Affiliation:

1. Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, TIMI Study Group, Boston, Massachusetts

2. Duke Clinical Research Institute, Durham, North Carolina

3. Policlinico San Matteo, Pavia, Italy

4. Merck & Co, Kenilworth, New Jersey

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?;Expert Review of Cardiovascular Therapy;2024-09

2. Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond;American Journal of Preventive Cardiology;2024-09

3. PCSK9 inhibitor effectively alleviated cognitive dysfunction in a type 2 diabetes mellitus rat model;PeerJ;2024-08-14

4. Early Management of Blood Lipid Levels with Non-Statin Lipid-Lowering Drugs in Acute Coronary Syndrome: A Mini Review;Cardiovascular Drugs and Therapy;2024-06-29

5. The Evaluation of Lipid-Lowering Treatment in Patients with Acute Coronary Syndrome in a Hungarian Invasive Centre in 2015, 2017, and during the COVID-19 Pandemic—The Comparison of the Achieved LDL-Cholesterol Values Calculated with Friedewald and Martin–Hopkins Methods;Journal of Clinical Medicine;2024-06-11